Viewing Study NCT02092259


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-24 @ 2:44 PM
Study NCT ID: NCT02092259
Status: UNKNOWN
Last Update Posted: 2015-07-14
First Post: 2014-03-17
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Sponsor: Luminex Corporation
Organization:

Study Overview

Official Title: A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay in Patients With Signs and Symptoms of Acute Gastroenteritis
Status: UNKNOWN
Status Verified Date: 2015-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The ARIES Norovirus Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of Norovirus GI/GII RNA from stool specimens obtained from symptomatic patients.

The purpose of this study is to establish the diagnostic accuracy of ARIES Norovirus Assay.
Detailed Description: The ARIES Norovirus Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of Norovirus GI/GII RNA from stool specimens obtained from symptomatic patients.

The objective is to establish the diagnostic accuracy of the ARIES Norovirus assay through a multi-site, method comparison on prospectively collected leftover, stool specimens. Diagnostic accuracy will be expressed in terms of clinical sensitivity (or positive agreement) and specificity (or negative agreement)

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: